Cargando…

44. Cost Effectiveness and Clinical Outcomes of Long Acting Lipoglycopeptides Used in Transitions of Care for Deep-Seated Infections

BACKGROUND: Dalbavancin and oritavancin are long-acting lipoglycopeptides (LaLGPs) FDA-approved for one-time only dosing for skin and skin structure infections. The use of these agents in serious, deep-seated infections requiring protracted antibiotic courses is of increasing interest. The purpose o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Antosz, Kayla S, Justo, Julie Ann, Al-hasan, Majdi N, Tabor, Benjamin, Kohn, Joseph, Milgrom, Alexander, Lu, Kevin, Brandon Bookstaver, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644188/ http://dx.doi.org/10.1093/ofid/ofab466.246

Ejemplares similares

Clinical Utility and Cost Effectiveness of Long-Acting Lipoglycopeptides Used in Deep-Seated Infections among Patients with Social and Economic Barriers to Care
por: Antosz, Kayla, et al.
Publicado: (2021)

Show me the data: A statewide comparative report of National Healthcare Safety Network (NHSN) Antimicrobial Use Option standardized antimicrobial administration ratios (SAARs)
por: Winders, Hana R., et al.
Publicado: (2022)

851. Validation of Quick Pitt Bacteremia Score in Patients with Staphylococcus aureus Bloodstream Infection
por: Elizabeth. Battle, Sarah, et al.
Publicado: (2019)

1841. Incidence and Predictors of Complications in Gram Negative Bloodstream Infection
por: Mondal, Utpal, et al.
Publicado: (2022)

1043. Evaluation of Early Clinical Failure Criteria for Gram-Negative Bloodstream Infections
por: Rac, Hana, et al.
Publicado: (2018)

Utility of Combination Antimicrobial Therapy in Adults with Bloodstream Infections due to Enterobacteriaceae and Non-Fermenting Gram-Negative Bacilli Based on In Vitro Analysis at Two Community Hospitals
por: Foster, Rachel A., et al.
Publicado: (2019)

Impact of follow up blood cultures on outcomes of patients with community-onset gram-negative bloodstream infection
por: Amipara, Rajiv, et al.
Publicado: (2021)

Impact of Reappraisal of Fluoroquinolone Minimum Inhibitory Concentration Susceptibility Breakpoints in Gram-Negative Bloodstream Isolates
por: Shealy, Stephanie C., et al.
Publicado: (2020)

122. Evaluation of Early Clinical Failure Criteria in Patients with Enterococcus Species Bloodstream Infection
por: Powers, Caroline, et al.
Publicado: (2019)

Direct Measurement of Performance: A New Era in Antimicrobial Stewardship
por: Al-Hasan, Majdi N., et al.
Publicado: (2019)

Optimization of Empirical Antimicrobial Therapy in Enterobacterales Bloodstream Infection Using the Extended-Spectrum Beta-Lactamase Prediction Score
por: Haimerl, Brian J., et al.
Publicado: (2023)

290. Impact of follow up blood cultures on outcomes of patients with gram-negative bloodstream infections
por: Amipara, Rajiv G, et al.
Publicado: (2020)

313. Using a Clinical Decision Prediction Tool to Improve Empirical Antimicrobial Therapy in Ceftriaxone-Resistant Enterobacterales Bloodstream Infections
por: McDougal, Elizabeth, et al.
Publicado: (2020)

Application of Standardized Antimicrobial Administration Ratio as a Motivational Tool within a Multi-Hospital Healthcare System
por: Shealy, Stephanie, et al.
Publicado: (2021)

Long-Acting Lipoglycopeptides: “Lineless Antibiotics” for Serious Infections in Persons Who Use Drugs
por: Morrisette, Taylor, et al.
Publicado: (2019)

Telavancin: A novel lipoglycopeptide antibiotic
por: Damodaran, S. E., et al.
Publicado: (2011)

Evaluating appropriateness and diagnostic stewardship opportunities of multiplex polymerase chain reaction gastrointestinal testing within a hospital system
por: O’Neal, Melissa, et al.
Publicado: (2020)

Candida parapsilosis bloodstream infection in an immunocompromised host with discordant multiplex polymerase chain reaction and conventional blood culture results: a case report
por: Jones, Jordan, et al.
Publicado: (2022)

1298. Validation of Local Pseudomonas aeruginosa Risk Factors in Patients with Community-Onset Bacterial Pneumonia
por: Pizzuti, Morgan, et al.
Publicado: (2021)

2399. Changing Demographics of Infective Endocarditis in South Carolina: An Ecological Study
por: Garrison, Phillip G, et al.
Publicado: (2023)

617. Long Acting Lipoglycopeptide Use in Veterans for Serious Gram-Positive Infections in the COVID Era
por: Saldana, Carlos S, et al.
Publicado: (2021)

Antibiotic lock therapy: review of technique and logistical challenges
por: Justo, Julie Ann, et al.
Publicado: (2014)

Successful use of nafcillin and ceftaroline combination therapy for persistent MSSA bacteraemia and endocarditis: a case series
por: Warren, Erin F, et al.
Publicado: (2022)

1388. Epidemiology and Treatment Outcomes of Nontuberculous Mycobacterial Infections at a Community Teaching Hospital in the Southeastern United States
por: Vivian Tsai, Y, et al.
Publicado: (2021)

Epidemiology, Outcomes and Tolerability of Protracted Treatment of Nontuberculous Mycobacterial Infections at a Community Teaching Hospital in the Southeastern United States
por: Tsai, Yuwei Vivian, et al.
Publicado: (2022)

2733. Association Between Influenza Vaccination Coverage and Ambulatory Antibiotic Prescription Rates in Children in South Carolina
por: Younas, Mariam, et al.
Publicado: (2019)

715 Impact of Fluoroquinolone Resistance on Community-Onset Gram-Negative Bloodstream Infections
por: Brigmon, Matthew, et al.
Publicado: (2014)

Pharmacist-Driven Culture and Sexually Transmitted Infection Testing Follow-Up Program in the Emergency Department
por: Shealy, Stephanie C., et al.
Publicado: (2020)

614. Long-Acting Lipoglycopeptides for the Treatment of Bone and Joint Infections and Bacteremia in Infectious Disease Outpatient Infusion Clinics
por: Metzger, Brian S, et al.
Publicado: (2020)

243. Temporal Trends in Appropriateness of Ambulatory Antibiotic Prescribing in South Carolina
por: Winders, Hana R, et al.
Publicado: (2020)

Specific Inhibition of VanZ-Mediated Resistance to Lipoglycopeptide Antibiotics
por: Sur, Vishma Pratap, et al.
Publicado: (2021)

Long-Acting Lipoglycopeptides for Gram-Positive Bacteremia at the End of Life to Facilitate Hospice Care: A Report of 3 Cases
por: Datta, Rupak, et al.
Publicado: (2018)

Current and future options for treating complicated skin and soft tissue infections: focus on fluoroquinolones and long-acting lipoglycopeptide antibiotics
por: Eckmann, Christian, et al.
Publicado: (2021)

Change in Antimicrobial Use During COVID-19 Pandemic in South Carolina Hospitals: A Multicenter Observational Cohort Study
por: Winders, Hana R., et al.
Publicado: (2021)

Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections
por: Brade, Karrine D., et al.
Publicado: (2016)

975. Clostridium difficile Infection and Antibiotic Prescription Rates in the Community: Explaining the Gender Gap
por: Younas, Mariam, et al.
Publicado: (2018)

Penicillin Allergy Skin Testing in the Inpatient Setting
por: Justo, Julie Ann, et al.
Publicado: (2019)

Telavancin, a new lipoglycopeptide antimicrobial, in complicated skin and soft tissue infections
por: Jafari Saraf, Lida, et al.
Publicado: (2011)

Engineered biosynthesis of enduracidin lipoglycopeptide antibiotics using the ramoplanin mannosyltransferase Ram29
por: Wu, Ming-Cheng, et al.
Publicado: (2015)

231. Retrospective Comparison of Intravenous Therapy, Oral Therapy, and Lipoglycopeptides for the Treatment of Osteomyelitis
por: Stumphauzer, Alex, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6aemjn7hcl4nbr1qqdibqqnpov